trial

Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies

NCTId NCT02670447
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 80 (estimated)
Sponsored by Centre Hospitalier Universitaire de Saint Etienne
Primary completion 2030-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
80 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2025-12-11
Primary completion
2030-04
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
MRI

Sponsors

Centre Hospitalier Universitaire de Saint EtienneLead Sponsor
Ministry of Health, FranceCollaborator

Investigators

1
Eric FAKRA, MD PhDPrincipal Investigator

Sites

5 total
Bron, FranceClermont-Ferrand, FranceGrenoble, FranceLyon, FranceSaint-Etienne, France

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2030-04
Status
RECRUITING
relationships
The graph out of here
drug
MRI
drug
lead_sponsor
Centre Hospitalier Universitaire de Saint Etienne
company
collaborator
Ministry of Health, France
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Eric FAKRA, MD PhD
person